— Know what they know.
Not Investment Advice

CRY

Artivion, Inc.
1W: -4.1% 1M: -8.7% 3M: -15.2% 1Y: -29.2% 3Y: -36.4% 5Y: -5.4%
$17.88
Last traded 2022-01-21 — delisted
NYSE · Healthcare · Medical - Devices · $725.1M
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$725.1M
52W Range17.49-18.22
Volume257,460
Avg Volume200,073
Beta1.53
Dividend$0.40
Analyst Ratings
6 Buy 3 Hold 0 Sell
Consensus Buy
Company Info
CEOJames Mackin
Employees1,200
SectorHealthcare
IndustryMedical - Devices
IPO Date1993-02-12
1655 Roberts Blvd NW
Kennesaw, GA 30144
US
17704193355
About Artivion, Inc.

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

Recent Insider Trades

NameTypeSharesPriceDate
Salveson Jon W A-Award 4,423 $29.39 2021-06-01
MORGAN HARVEY A-Award 4,423 $29.39 2021-06-01
Burbank Jeffrey H A-Award 4,423 $29.39 2021-06-01
Horton Amy M-Exempt 2,700 $11.00 2021-04-30
Horton Amy S-Sale 2,700 $30.00 2021-04-30

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms